GROWBlox Sciences, Inc.’s (GBLX) Advantageous Approach to Medical Cannabis Highlighted at CannabisFN
CannabisFN this morning highlighted GROWBlox Sciences’ role in the cannabis and pharmaceutical industries, paying particular attention to the company’s “unique business model, long-term potential in pharmaceuticals, and short-term potential in raw material sales.” Read the full report here: http://www.marketwatch.com/story/growblox-sciences-takes-integrated-approach-to-cannabis-medicine-2015-05-25?page=1 Twenty three U.S. states and the District of Columbia have legalized marijuana, and according to IBISWorld estimates, broader acceptance of cannabinoid-based therapies throughout the U.S. has spurred the medical cannabis industry’s CAGR of 16.2% to reach $2 billion in revenue between 2009 and 2014. As CannabisFN points out, GROWBlox Sciences stands out from numerous would-be competitors in the industry with its…